| Literature DB >> 28045404 |
Yukinori Koyama, David A Brenner.
Abstract
Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the initiation of inflammation, which activates immune cells. While Kupffer cells are the resident macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes, neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate hepatic stellate cells, which are the major source of myofibroblasts in the liver. Here we review the initiation of inflammation in the liver, the liver inflammatory cells, and their crosstalk with myofibroblasts.Entities:
Mesh:
Year: 2017 PMID: 28045404 PMCID: PMC5199698 DOI: 10.1172/JCI88881
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808